I learned from the news that the U.S. researchers have launched a study to examine whether an omega-3 fatty acid called docosahexaenoic acid (DHA) can help slow the progression of Alzheimer's disease.
According to the news, the 18-month clinical trial that is supported by the National Institute on Aging (NIA) will be conducted at 52 sites across the United States and will seek to enroll 400 people, age 50 and older, with mild to moderate Alzheimer's disease.
Publish Date: June 11, 2007
No comments:
Post a Comment